The Didanosine Tablets, cataloged under National Stock Number 6505-01-354-3146, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. Government technical data includes 4 specifications, cited from the U.S. Government catalog. 4 additional reference documents (drawings, advisory and superseded references) are recorded in the U.S. Government catalog. 1 item shares a part number with this NSN in the catalog (possible match — not a government interchangeability claim). Current acquisition status: Active.
| Parameter | Value |
|---|---|
| NSN | 6505-01-354-3146 |
| Item Name | Didanosine Tablets |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Status | ACTIVE |
| Primary Container Content Quantity | 60.000 TABLETS |
| Supplementary Features | MEDSEP ITEM FOR DOD; BRISTOL-MYERS SQUIBB PHARMACEUTIALS |
| Primary Container Type | BOTTLE |
| Active Medicament Medicinal Strength | 100.000 MILLIGRAMS DIDANOSINE ACTIVE INGREDIENT |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Possible hazard — SDS may be required (DLA HMIC P) |
| Criticality Code | X |
| Reference | Meaning |
|---|---|
| VIDEX | 5/9 Secondary reference Bristol-Myers Squibb Pharmaceutical Co Apothecon Div |
| 6627-03 | 3/9 Design control — primary reference Bristol-Myers Squibb Pharmaceutical Co Apothecon Div |
| A92A240 | 5/1 Secondary reference Department of the Army U S Army Medical Material Agency Mcmr-Mmo-Sa |
| NDC00087-6627-43 | 5/9 Secondary reference Bristol-Myers Squibb Pharmaceutical Co Apothecon Div |
NSN 6505-01-354-3146 is a Didanosine Tablets, classified under FSC 6505, Drugs and Biologicals. Status: active.
1 possible match (shared part number, not a government interchangeability claim): 6505-01-354-9490. Verify interchangeability with system specifications before substitution.
Key specifications for 6505-01-354-3146: Primary Container Content Quantity: 60.000 TABLETS; Supplementary Features: MEDSEP ITEM FOR DOD; BRISTOL-MYERS SQUIBB PHARMACEUTIALS; Primary Container Type: BOTTLE; Special Features: TABLET MUST BE EITHER CHEWED OR CRUSHED IN WATER; USED TO TREAT ADVANCED HIV INFECTIONS. 4 specifications are documented in the U.S. Government catalog.
Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.